-
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at HC Wainwright
Source: Buzz FX / 15 Oct 2024 08:47:12 America/Chicago
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat October 15, 2024 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reaffirmed by investment an
Read more...